Investment Co PJSC Mubadala - Oct 27, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
10%+ Owner
Signature
/s/ Samer Halawa, Chief Legal Officer, Mubadala Investment Company PJSC (6)
Stock symbol
RXRX
Transactions as of
Oct 27, 2022
Transactions value $
$24,999,996
Form type
4
Date filed
10/31/2022, 04:08 PM
Next filing
Jan 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $25M +2.55M +29.18% $9.80 11.3M Oct 27, 2022 See Explanation of Responses F1, F2, F4, F5
holding RXRX Class A Common Stock 7.06M Oct 27, 2022 See Explanation of Responses F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 24, 2022, Recursion Pharmaceuticals, Inc. (the "Issuer") entered into a securities purchase agreement with Fifteenth Investment Company LLC, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $24,999,996.00, 2,551,020 shares of Class A Common Stock, $0.00001 par value per share (the "PIPE Shares") of the Issuer's common stock at a price of $9.80 per share.
F2 Consists of (i) 11,291,937 shares held of record by Fifteenth Investment Company LLC and (ii) 0 shares held of record by Thirty Fifth Investment Company LLC, as a result of a transfer of 5,963,140 shares to Fifteenth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.
F3 MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.
F4 Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F5 Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Remarks:

6. The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act.